glp-1 announcement New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Brands Enter Their Super

The FDA has issued multiple warnings about these products because of: Unknown quality Incorrect or impure ingredient (salt forms) Lack of sterility Incorrect dosing Risk of contamination Therefore, only use FDA-approved peptides or get your medication from a certified healthcare provider or a 503a compounding pharmacy

Anti Wrinkle Injection Results When to Expect What Results develop progressively rather than appearing immediately

Tauroursodeoxycholic acid mitigates depression-like behavior and hippocampal neuronal damage in a corticosterone model of female mice

We may verify your identity and authority before responding